207 related articles for article (PubMed ID: 29627705)
1. 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis.
Pérez-Treviño P; la Cerda HH; Pérez-Treviño J; Fajardo-Ramírez OR; García N; Altamirano J
Transl Oncol; 2018 Jun; 11(3):672-685. PubMed ID: 29627705
[TBL] [Abstract][Full Text] [Related]
2. Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging.
Miyashita M; Gonda K; Tada H; Watanabe M; Kitamura N; Kamei T; Sasano H; Ishida T; Ohuchi N
Cancer Med; 2016 Oct; 5(10):2813-2824. PubMed ID: 27666577
[TBL] [Abstract][Full Text] [Related]
3. Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer.
Xiang QM; Wang LW; Yuan JP; Chen JM; Yang F; Li Y
Exp Mol Pathol; 2015 Aug; 99(1):133-8. PubMed ID: 26102249
[TBL] [Abstract][Full Text] [Related]
4. Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade.
Batalha S; Gomes CM; Brito C
Front Immunol; 2023; 14():1267621. PubMed ID: 38022643
[TBL] [Abstract][Full Text] [Related]
5. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity.
Chen C; Peng J; Xia H; Wu Q; Zeng L; Xu H; Tang H; Zhang Z; Zhu X; Pang D; Li Y
Nanotechnology; 2010 Mar; 21(9):095101. PubMed ID: 20110584
[TBL] [Abstract][Full Text] [Related]
6. Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
Muraro E; Comaro E; Talamini R; Turchet E; Miolo G; Scalone S; Militello L; Lombardi D; Spazzapan S; Perin T; Massarut S; Crivellari D; Dolcetti R; Martorelli D
J Transl Med; 2015 Jun; 13():204. PubMed ID: 26116238
[TBL] [Abstract][Full Text] [Related]
7. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer.
Chen C; Peng J; Xia HS; Yang GF; Wu QS; Chen LD; Zeng LB; Zhang ZL; Pang DW; Li Y
Biomaterials; 2009 May; 30(15):2912-8. PubMed ID: 19251316
[TBL] [Abstract][Full Text] [Related]
8. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
[TBL] [Abstract][Full Text] [Related]
9. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
Qi S; Hoppmann S; Xu Y; Cheng Z
Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
[TBL] [Abstract][Full Text] [Related]
10. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
11. [
Kondo M; Cai Z; Chan C; Forkan N; Reilly RM
EJNMMI Radiopharm Chem; 2023 Sep; 8(1):24. PubMed ID: 37750937
[TBL] [Abstract][Full Text] [Related]
12.
Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
[TBL] [Abstract][Full Text] [Related]
13. Ratiometric fluorescence molecularly imprinted sensor based on dual-emission quantum dots hybrid for determination of tetracycline.
Wei X; Chen H
Anal Bioanal Chem; 2019 Sep; 411(22):5809-5816. PubMed ID: 31292702
[TBL] [Abstract][Full Text] [Related]
14. Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging.
Zielinski R; Hassan M; Lyakhov I; Needle D; Chernomordik V; Garcia-Glaessner A; Ardeshirpour Y; Capala J; Gandjbakhche A
PLoS One; 2012; 7(7):e41016. PubMed ID: 22911732
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
